SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: joe wiles who wrote (10777)11/4/1998 5:19:00 PM
From: AgAuUSA  Read Replies (1) | Respond to of 14328
 
I like that: Giddy Greg. If you hold this stock....you will be giddy too!!!

Thanks for your comments. Of course, debt is for acquisitions which will be acretive. Their cash went for the same. The inventories are worthless till sold, true. I have no doubt they are good as sold.

You missed the earnings which are up substantially over last year on the 33% more shares. Hey, if they can increase earnings at 100% per year they can sell 33% more shares!! Making more and more money!!! I like that!!! Just my opinion.

Still buying!!! And, again, thanx to the sellers and buyers. What a market!!!

Looking forward to the CC!!!

Giddy



To: joe wiles who wrote (10777)11/17/1998 9:19:00 PM
From: Scott H. Davis  Respond to of 14328
 
Old response to Joe and Greg RE: Book values and other FA componants. Greg, I'm not sure what you are using as the source of your book value, but WSRN has it quite differently.

wsrn.com

The FA is a mixed bag. Current ratio is not real good, margins ok, great ROE, ROA not so. These combined with P/Book & P/Sales do not qualify as a value play. Perhaps a growth play with some value backup.

Joe, I do find a material improvement over last year.

For comparison, here's some more solid, consistant FA

wsrn.com